Scienture Patents – Insights & Stats (Updated 2023)

Scienture has a total of 16 patents globally, out of which none have been granted. Of these 16 patents, more than 75% patents are active. The USA is where Scienture has filed the maximum number of patents. Parallelly, the USA seems to be the main focused R&D center of Scienture and is also the origin country of the firm.

Scienture was founded in the year 2019 by Shankar Hariharan. The company is a pharmaceutical research firm used to focus on drug screening.

Do read about some of the most popular patents of Scienture which have been covered by us in this article and also you can find Scienture patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Scienture patent portfolio.

How many patents does Scienture have?

Scienture has a total of 16 patents globally. These patents belong to 4 unique patent families. Out of 16 patents, 12 patents are active.

How Many Patents did Scienture File Every Year?

Scienture Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

How many Scienture patents are Alive/Dead?

Worldwide Patents

Scienture Patent Portfolio

How Many Patents did Scienture File in Different Countries?

Scienture Worldwide Patent Filing

Countries in which Scienture Filed Patents

CountryPatents
Canada3
United States Of America3
Europe (EPO)3
Japan3

Where are Research Centres of Scienture Patents Located?

The R&D Centres of patents filed by Scienture is in the US.

List of Scienture Patents

Scienture PatentsTitle
US20230218582A1Losartan Liquid Formulations And Methods Of Use
US20230137010A1Long-Acting Apomorphine Formulations And Injectors For Therapeutic Delivery Of The Same
US20230043204A1Dihydroergotamine Mesylate Formulations And Pre-Filled Injectors For Therapeutic Delivery Of The Same
EP4004138A4Dihydroergotamine Mesylate Formulations And Pre-Filled Injectors For Therapeutic Delivery Of The Same
EP4138783A1Long-Acting Bupivacaine Microsphere Formulations
EP4132475A2Long-Acting Apomorphine Formulations And Injectors For Therapeutic Delivery Of The Same
CA3180971A1Long-Acting Bupivacaine Microsphere Formulations
CA3179866A1Long-Acting Apomorphine Formulations And Injectors For Therapeutic Delivery Of The Same
CA3151950A1Dihydroergotamine Mesylate Formulations And Pre-Filled Injectors For Therapeutic Delivery Of The Same
JP2023522987ALong-Acting Bupivacaine Microsphere Formulation
JP2023522134ALong-Acting Apomorphine Formulations And Injectors For Their Therapeutic Delivery
JP2023507890ADihydroergotamine Mesylate Formulations And Prefilled Syringes For Their Therapeutic Delivery
WO2022076746A1Losartan Liquid Formulations And Methods Of Use
WO2021207737A3Long-Acting Apomorphine Formulations And Injectors For Therapeutic Delivery Of The Same
WO2021216928A1Long-Acting Bupivacaine Microsphere Formulations
WO2021133744A1Dihydroergotamine Mesylate Formulations And Pre-Filled Injectors For Therapeutic Delivery Of The Same

What are Scienture’s key innovation segments?

What Technologies are Covered by Scienture?

The chart below distributes patents filed by Scienture in different countries on the basis of the technology protected in patents. It also represents the markets where Scienture thinks it’s important to protect particular technology inventions.

R&D Focus: How has Scienture’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Scienture?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.